The Novel Allosteric NEK7 Inhibitor Ofirnoflast (HT-6184) Demonstrates Robust and Sustained Hematologic Response in Subjects with IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndrome ...
The Healthy @Reader's Digest on MSN
Here’s How Long Most People Stay on a Weight-Loss Drug, Say Obesity Medicine Doctors
How long would you need to jab yourself...and contend with the cost? Two MDs specializing in weight loss and endocrinology share how it works.
The neuroprotective effects of GLP-1RAs were most pronounced among patients with lower baseline cognition in type 2 diabetes.
Hyderabad: On the occasion of World Diabetes Day, Consultant Endocrinologist Dr. B. Sravya and Consultant Diabetologist Dr.
Hyderabad: The Asian Institute of Nephrology & Urology (AINU) has launched a Men’s Wellness Program at its Banjara Hills ...
Three Cochrane reviews show GLP-1 drugs reduce weight, yet uncertainties remain about long-term safety and equity of access.
High intake of ultra-processed foods in young adults is linked to higher odds of prediabetes, impaired glucose tolerance, and ...
FILE - This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File) FILE - This photo shows Novo Nordisk headquarters in ...
Hosted on MSN
The Obesity-Drug Revolution Is Stalling
For most of my adult life, I’ve felt helpless about being overweight. When I met with a doctor a few years ago to discuss my high cholesterol, he held up a hunk of faux flesh meant to model a pound of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback